PMID- 7934311 OWN - NLM STAT- MEDLINE DCOM- 19941107 LR - 20181130 IS - 0379-0355 (Print) IS - 0379-0355 (Linking) VI - 16 IP - 5 DP - 1994 Jun TI - In vitro vasorelaxant and in vivo cardiovascular effects of S-nitrosothiols: comparison to and cross tolerance with standard nitrovasodilators. PG - 323-35 AB - The in vitro vasorelaxant and in vivo cardiovascular effects of synthetic S-nitrosothiols (RSNOs) were compared to standard nitrovasodilators. S-Nitroso-glutathione (GSNO), S-nitroso-N-acetylcysteine (NACysNO), S-nitroso-galactopyranose (GPSNO), S-nitroso-thioglycerol (TGSNO) and S-nitroso-homocysteine (HCysNO) relaxed phenylephrine (PE) contracted rabbit aorta at 50% effective concentrations (EC50s) of 3-46 nM. While nitroglycerin (GTN) exhibited in vitro tolerance after preincubation, the RSNOs were considerably less cross tolerant to GTN. In conscious dogs, GSNO, NACysNO and GPSNO (1-20 mcg/kg/min i.v.) paralleled nitroprusside (SNP) in reducing mean arterial and central venous pressure (MAP; CVP) with mild tachycardia. GSNO, NACysNO and SNP were more hypotensive and more resistant to isosorbide dinitrate (ISDN) cross tolerance than GTN. NACysNO showed mild self tolerance with low infusion (2.5 mcg/kg/min x 4h x 3 days) and blunted GTN's hypotension. These studies demonstrate that GSNO and NACysNO are SNP-like vasodilators in conscious dogs, which exhibit less cross tolerance to ISDN than GTN. Further, RSNOs relax vascular smooth muscle seemingly independent of nitric oxide (NO) liberation, and nitrate tolerance may involve reduced RSNO formation or NO release rather than desensitized guanylate cyclase (GC). FAU - Smith, M P AU - Smith MP AD - Cardiovascular Diseases Unit, Upjohn Laboratories, Upjohn Company, Kalamazoo, MI. FAU - Humphrey, S J AU - Humphrey SJ FAU - Kerr, S W AU - Kerr SW FAU - Mathews, W R AU - Mathews WR LA - eng PT - Comparative Study PT - Journal Article PL - Spain TA - Methods Find Exp Clin Pharmacol JT - Methods and findings in experimental and clinical pharmacology JID - 7909595 RN - 0 (Nitroso Compounds) RN - 0 (S-Nitrosothiols) RN - 0 (Sulfhydryl Compounds) RN - 0 (Vasodilator Agents) RN - 31C4KY9ESH (Nitric Oxide) RN - 60-24-2 (Mercaptoethanol) RN - 67616-44-8 (S-nitrosomercaptoethanol) SB - IM MH - Animals MH - Blood Pressure/drug effects MH - Cardiovascular System/*drug effects MH - Dogs MH - Drug Tolerance MH - Female MH - Heart Rate/drug effects MH - In Vitro Techniques MH - Male MH - *Mercaptoethanol MH - Muscle Relaxation/*drug effects MH - Muscle, Smooth, Vascular/*drug effects/metabolism/physiology MH - Nitric Oxide/physiology MH - Nitroso Compounds/*pharmacology MH - Rabbits MH - *S-Nitrosothiols MH - Sulfhydryl Compounds/*pharmacology MH - Time Factors MH - Vasodilator Agents/*pharmacology EDAT- 1994/06/01 00:00 MHDA- 1994/06/01 00:01 CRDT- 1994/06/01 00:00 PHST- 1994/06/01 00:00 [pubmed] PHST- 1994/06/01 00:01 [medline] PHST- 1994/06/01 00:00 [entrez] PST - ppublish SO - Methods Find Exp Clin Pharmacol. 1994 Jun;16(5):323-35.